Investment View
MST values Recce Pharmaceuticals at A$441m or A$2.54 per share on an undiluted basis, versus a bear case of A$1.85 per share, using a risk-adjusted net present value (rNPV) method and including A$22.9m in cash as at 31 March 2021.
Investment ViewMST values Recce Pharmaceuticals at A$441m or...
-
- There are more pages in this discussion • 928 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
51.0¢ |
Change
-0.015(2.86%) |
Mkt cap ! $118.1M | |||
| Open | High | Low | Value | Volume |
| 52.0¢ | 52.0¢ | 50.5¢ | $40.89K | 79.63K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 677 | 51.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 52.5¢ | 392 | 1 |
View Market Depth
| Last trade - 15.59pm 13/09/2024 (20 minute delay) ? |
| RCE (ASX) Chart |